Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiological classification of Raynaud's phenomenon

K H Nilsen

    The British Journal of Dermatology
    |January 1, 1980
    PubMed
    Summary

    This study found that Raynaud

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Virkersund Spa. Changes in patient admission and therapeutic outcome over the last 15 years].

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1999
    Same author

    [From spas and convalescent homes to retraining institutions].

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1996
    Same author

    Assessment of the progress of the back-pain patient 1981 Volvo Award in Clinical Science.

    Spine·1982
    Same author

    Evaluation of low back pain and assessment of lumbar corsets with and without back supports.

    Annals of the rheumatic diseases·1981
    Same author

    Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.

    British medical journal·1980
    Same author

    Reactive hyperemia in scleroderma.

    The Journal of investigative dermatology·1979

    Area of Science:

    • Rheumatology
    • Vascular Medicine
    • Immunology

    Background:

    • Raynaud's phenomenon is a condition affecting blood vessels, often triggered by cold or stress.
    • It can be associated with autoimmune diseases like systemic sclerosis and rheumatoid arthritis.
    • Understanding the underlying mechanisms is crucial for effective treatment.

    Purpose of the Study:

    • To investigate the distinct pathophysiological mechanisms in different patient groups with Raynaud's phenomenon.
    • To determine if patient classification based on underlying mechanisms is more effective for treatment studies.
    • To highlight the heterogeneity within clinically defined groups of Raynaud's phenomenon.

    Main Methods:

    • Thirty-six patients were divided into three groups: primary Raynaud's disease, systemic sclerosis, and rheumatoid arthritis.
    • Underlying mechanisms of Raynaud's phenomenon were assessed separately within each group.
    • Clinical classifications were based on strict diagnostic definitions.

    Main Results:

    • Significant pathophysiological heterogeneity was observed within each of the three clinical groups.
    • The underlying mechanisms contributing to Raynaud's phenomenon varied considerably among patients.
    • This heterogeneity suggests that a 'one-size-fits-all' approach to treatment may not be optimal.

    Conclusions:

    • Patient selection for treatment studies should prioritize underlying pathophysiological mechanisms over associated disorders.
    • Recognizing and addressing specific mechanisms can lead to more targeted and effective therapies for Raynaud's phenomenon.
    • Future research should focus on mechanism-based stratification for clinical trials in Raynaud's phenomenon.

    Related Experiment Videos